CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to qualify new safety biomarkers to enhance drug development and patient safety. It involves generating data for regulatory acceptance and developing diagnostic tools to improve disease diagnosis.
Qualified biomarkers help to optimize drug development and patient safety, yet for the regulatory acceptance of safety biomarkers substantial sample sizes are needed to ensure adequate case and control numbers, and robust evidence sufficient for qualification.
To address this challenge, a consortium of leading European research institutions and SMEs has been established.
The consortium will generate exploratory and confirmatory data enabling regulatory qualification of new safety biomarkers for…
UNIVERSITAT ZURICH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Malaga
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA
Luxembourg, ESCH SUR ALZETTE
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
LANDSPITALI UNIVERSITY HOSPITAL
Iceland, Reykjavik
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, MUNCHEN
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 keywords.
